Clinical Trial Update: Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of Chronocort in adults with congenital adrenal hyperplasia completed, with results evaluating pharmacokinetics and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency
• Congenital Adrenal Hyperplasia

Drugs mentioned

• Chronocort

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Endocrine Disease, Adrenal Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2017-05-17